Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantation
- 1 January 2004
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 93 (2), 247-250
- https://doi.org/10.1016/j.amjcard.2003.09.054
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Dalteparin as Periprocedure Anticoagulation for Patients on Warfarin and at High Risk of ThrombosisAnnals of Pharmacotherapy, 2001
- Managing Oral Anticoagulant TherapyChest, 2001
- Low Molecular Weight Heparin After Mechanical Heart Valve ReplacementCirculation, 2000
- Economic Evaluation of Outpatient Treatment With Low-Molecular-Weight Heparin for Proximal Vein ThrombosisArchives of Internal Medicine, 1999
- Use of enoxaparin for the chronically anticoagulated patient before and after proceduresThe American Journal of Cardiology, 1999
- Low-Molecular-Weight Heparins Compared with Unfractionated Heparin for Treatment of Acute Deep Venous Thrombosis: A Cost-Effectiveness AnalysisAnnals of Internal Medicine, 1999
- Low-Molecular-Weight Heparins Compared with Unfractionated Heparin for Treatment of Acute Deep Venous ThrombosisAnnals of Internal Medicine, 1999
- Guidelines for the Management of Patients With Valvular Heart DiseaseCirculation, 1998
- A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein ThrombosisNew England Journal of Medicine, 1996
- Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at HomeNew England Journal of Medicine, 1996